Global Haematology Market – Industry Trends and Forecast to 2029

Análise e dimensão do mercado de hematologia

O mercado da hematologia será provavelmente impulsionado pelas taxas de instrumentos de hematologia automatizados e pelas preferências por testes hematológicos de alta sensibilidade no local de atendimento (POC). Os rápidos avanços tecnológicos, como a aplicação de técnicas fundamentais de citometria de fluxo e a expansão de analisadores hematológicos de alto rendimento, também deverão ter um impacto significativo nos impulsionadores do setor.

A Data Bridge Market Research analisa que o mercado de hematologia que foi de 2,13 mil milhões de dólares em 2021, subiria para 2,96 mil milhões de dólares até 2029, e deverá passar por um CAGR de 4,20% durante o período de previsão de 2022 a 2029. Para além das perspetivas de mercado como o valor de mercado, a taxa de crescimento, os segmentos de mercado, a cobertura geográfica, os participantes do mercado e o cenário de mercado, o relatório de mercado com curadoria da equipa de pesquisa de mercado da Data Bridge também inclui análise especializada aprofundada, epidemiologia do paciente, análise de pipeline, análise de preços, e quadro regulamentar.

Âmbito do relatório e segmentação de mercado

Definição de mercado

Os analisadores hematológicos são instrumentos médicos utilizados para classificar e contar o número de células sanguíneas na amostra de sangue de um paciente. As contagens diferenciais de leucócitos também são analisadas utilizando estes equipamentos. As características dos analisadores hematológicos variam de acordo com os diferentes equipamentos médicos, e os utilizadores podem especificar qual o serviço de teste ou análise que necessitam em função dessas características.

Dinâmica do mercado da hematologia

Motoristas

• Aumento de doenças crónicas

O aumento das doenças do sangue e de outras doenças, o rápido desenvolvimento da tecnologia hematológica e o aparecimento de analisadores hematológicos de alto rendimento são todos fatores na expansão do mercado da hematologia. Um dos principais fatores que influencia o mercado é a crescente incidência de doenças crónicas do sangue, que deverá aumentar a procura de analisadores hematológicos.

• Aumentar o investimento em infraestruturas de saúde

Outro fator significativo que influencia a taxa de crescimento do mercado da hematologia é o aumento dos gastos em saúde que ajuda a melhorar as suas infraestruturas. Além disso, várias organizações governamentais pretendem melhorar a infra-estrutura de cuidados de saúde através do aumento do financiamento, o que influenciará ainda mais a dinâmica do mercado.

Oportunidades

• Aumento das atividades de investigação e desenvolvimento

Além disso, prevê-se que as crescentes iniciativas de I&D que demonstrem a eficácia dos analisadores hematológicos beneficiem a expansão do mercado. Por exemplo, os analisadores hematológicos automatizados são frequentemente empregues em laboratórios médicos, de acordo com um artigo publicado em fevereiro de 2021 intitulado “Estabelecimento de critérios de revisão melhorados para analisadores hematológicos em instituições oncológicas”. O segmento de mercado dos analisadores hematológicos para deteção de marcadores de superfície celular irá crescer como resultado do ambiente hospitalar.

Restrições/Desafios

• Alto custo

Por outro lado, os enormes gastos com analisadores hematológicos, convocatórias de mercadorias e a lenta implementação de dispositivos hematológicos não convencionais nos países em desenvolvimento obstruirão a taxa de crescimento do mercado. A escassez de profissionais qualificados e a falta de infraestruturas de saúde nas economias em desenvolvimento desafiarão o mercado da hematologia.

Os recalls de produtos, a lenta adoção da tecnologia e as preocupações regulatórias e de reembolso vão restringir o mercado no período de previsão.

This haematology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the haematology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Haematology Market

The market has been slightly damaged by the COVID-19 pandemic. In order to measure COVID-19, haematological criteria are being stressed more widely. Using instruments like haematological analyzers, many hospitals have tested and kept track of COVID-19 patients. Important prognostic indicators such as lymphopenia, neutrophilia, leukocytosis, and thrombocytopenia—all of which are common findings in SARS-CoV-2 virus patients—can only be provided by a clinical haematology laboratory. Furthermore, hospitalization, pneumonia, and pain were more likely among COVID-19 and sickle cell disease (SCD) patients. SCD patients needed to have their health closely monitored since they were more prone to contract new infections. This had a big effect on the market.

Recent Development

• In June 2022, Thermo Fisher Scientific Inc., expanded its extensive line of automated connective tissue disease tests by releasing the new EliA RNA Pol III and EliA Rib-P blood tests to assist in the diagnosis of Systemic Sclerosis and Systemic Lupus Erythematosus (SLE)
• In May 2020, The DxH 690T haematology analyzer was introduced by Beckman Coulter, a division of Danaher Corporation, in the United States. It enables mid-volume laboratories to optimize uptime and streamline workflow.

Global Haematology Market Scope

The haematology market is segmented on the basis of product, reagent, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Haematology Analyzers
• Flow Cytometers
• Coagulation Analyzers
• Slide Stainers
• Centrifuges
• Hemoglobinometers
• Others

 Reagent

• Coagulation Reagents
• Flow Cytometery Reagents
• Immuno-Haematology Reagents
• Others

 Application

• Drug Testing
• Auto Immune Disease
• Cancer
• Diabetes Mellitus
• Infectious Disease
• Others

End User

• Hospitals
• Clinical Testing Institutes
• Patient Self-testing
• Other

Haematology Market Regional Analysis/Insights

The haematology market is analyzed and market size insights and trends are provided by country, product, reagent, application and end user as referenced above.

The countries covered in the haematology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the haematology market due to the growing geriatric population and innovative medical technology adoption.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and the growing demand of advanced medical technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Haematology Market Share Analysis

The haematology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to haematology market.

Some of the major players operating in the haematology market are:

• Siemens (Germany)
• Abbott (U.S.)
• Erba Mannheim (Germany)
• Abaxis (U.S.)
• Heska Corporation (U.S.)
• Sysmex Corporation (Japan)
• Danaher (U.S.)
• Nihon Kohden Corporation (Japan)
• Siemens (Germany)
• Abbott (U.S.)
• Boule Diagnostics (Sweden)
• HORIBA (Japan)
• Bio-Rad Laboratories Inc. (U.S.)
• BioSystems (U.S.)
• Diatron (Hungary)
• Drew Scientific (U.S.)
• EKF Diagnostics (U.K.)
• Mindray Medical India Pvt. Ltd. (China)
• Ortho Clinical Diagnostics (U.S.)

SKU-54760